KNOXVILLE, TN— Stephanie Mar­quart met the de­liv­ery guy be­fore he could reach her front door. She’d been ob­ses­sive­ly re­fresh­ing the track­ing page, trac­ing the...

When Base­camp Re­search start­ed out in 2019, its founders had to first con­vince in­vestors it could build a mas­sive ge­net­ic data­base. That meant gath­er­ing ge­net­ic...

The mon­ey con­tin­ues pour­ing in­to Enve­da.

The Col­orado and In­dia start­up, which scours the globe's plant and mi­crobe chem­istry to cre­ate the blue­print for its...

Plus, news about Cali­way and Bris­tol My­ers Squibb.

Ver­dict in Chi­nese vac­cine scan­dal:Gao Jun­fang, for­mer chair­woman of Chang­sheng Biotech­nol­o­gy, has been sen­tenced to life...

Roche moves clos­er to en­ter­ing an in­creas­ing­ly crowd­ed kid­ney dis­ease mar­ket where No­var­tis, Cal­lid­i­tas, Tra­vere, Ot­su­ka and Ve­ra al­ready have ap­proved drugs.

The Swiss phar­ma...

LON­DON — Many in­vestors were un­der­whelmed by No­vo’s ar­tic­u­la­tion of its strat­e­gy at the com­pa­ny’s cap­i­tal mar­kets day on Mon­day, and Mike Doust­dar knows it...